Ron Squarer

Biography

 Ron Squarer has served as Chief Executive Officer and a member of the Array Board of Directors since April 2012. Mr. Squarer has extensive commercial, development and executive leadership expertise from a greater than two decade career in the biopharmaceutical industry. Prior to this, Mr. Squarer held positions of increasing responsibility with Hospira Inc., a global pharmaceutical and medical device company, most recently serving as Senior Vice President, Chief Commercial Officer, where he was responsible for delivering $4 billion in annual revenue.  Mr. Squarer joined Hospira from Mayne Pharma, where he served as Senior Vice President, Global Corporate and Business Development when Mayne was sold to Hospira in 2007.  Prior to Mayne Pharma, Mr. Squarer held senior management roles at both Pfizer, Inc., and at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) in the U.S. and Europe. Mr. Squarer currently serves as a member of the Board of Directors of Retrophin, Inc. Mr. Squarer holds an MBA from the Kellogg School of Management, Northwestern University and a bachelor’s degree in biochemistry from the University of California, Berkeley.

Research Interest

 Biochemistry